Teams at Alector

Leads clinical development strategy and Phase 1 execution for AL137, an investigational neurodegenerative disease therapy. Provides medical leadership for protocol design, dose escalation, safety monitoring, data interpretation, benefit-risk assessment, regulatory interactions, and clinical decision-making. Partners cross-functionally with Clinical Operations, Translational Medicine, Safety, Biometrics, and Regulatory teams, while serving as the primary internal clinical expert. Applies AI and emerging technologies to improve drug-development efficiency.